Another GvHD study examining the role of MyD88, TRIF, TLR2/4, and TLR9 found that while deficiency in all these molecules decreased the intestinal immunopathology of GvHD, only TLR9 deficiency improved survival (73). This evidence concerns the gene MYD88 and graft versus host disease.